Back
Novo Nordisk AS Stock Predictions
Sponsored
NVO
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
28
NVO
Novo Nordisk AS
Last Price:
$86.36
Seasonality Move:
6.58%
7 Day Trial
ALL ACCESS PASS
$
7
Novo Nordisk AS Stock Forecast
-
Over the next 52 weeks, Novo Nordisk AS has on average historically risen by 19.4% based on the past 43 years of stock performance.
-
Novo Nordisk AS has risen higher in 33 of those 43 years over the subsequent 52-week period, corresponding to a historical accuracy of 76.74%
-
Is Novo Nordisk AS Stock Undervalued?The current Novo Nordisk AS [NVO] share price is $87.37. The Score for NVO is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Novo Nordisk AS Stock Go Up Next Year?
-
Over the next 52 weeks, Novo Nordisk AS has on average historically risen by 19.4% based on the past 43 years of stock performance.
Novo Nordisk AS Stock Rating
Sell
28
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS overpriced?
-
Novo Nordisk AS has risen higher in 33 of those 43 years over the subsequent 52-week period, corresponding to a historical accuracy of 76.74%
Novo Nordisk AS Stock Price History
Stock Information
Stock Info
Exchange:
NYSE
Country:
Denmark
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
novonordisk.com
52-Week Data
52-Week High:
148.15
52-Week Low:
81.50
Prediction Charts
Market Cap:
388B
Price in USD:
87.37
Volume:
6.1M
Beta:
0.48
Technical Analysis
SMA50:
106.79
SMA100:
117.69
SMA200:
125.34
52-Wk Change:
-15.73%
Stock Predictions
-
Is Novo Nordisk AS stock public?Yes, Novo Nordisk AS is a publicly traded company.
-
What is the Novo Nordisk AS stock quote today?The Novo Nordisk AS stock price is 87.37 USD today.
-
How to buy Novo Nordisk AS stock online?You can buy Novo Nordisk AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Dec-9 | 111.72 | 111.08 | 111.99 | 110.30 |
Dec-10 | 111.55 | 109.19 | 111.55 | 108.70 |
Dec-11 | 110.45 | 111.69 | 112.52 | 110.02 |
Dec-12 | 110.88 | 108.61 | 111.17 | 108.41 |
Dec-13 | 107.04 | 106.95 | 107.61 | 104.14 |
Dec-16 | 109.29 | 108.05 | 109.88 | 107.87 |
Dec-17 | 107.75 | 108.01 | 108.99 | 107.73 |
Dec-18 | 108.39 | 105.96 | 109.04 | 105.48 |
Dec-19 | 104.27 | 103.44 | 104.75 | 102.74 |
Dec-20 | 82.72 | 85.00 | 86.53 | 81.50 |
Dec-23 | 88.87 | 88.71 | 89.10 | 85.99 |
Dec-24 | 88.90 | 87.37 | 88.98 | 87.07 |
Dec-26 | 87.07 | 87.65 | 88.06 | 86.87 |
Dec-27 | 87.73 | 87.37 | 88.77 | 87.02 |
Novo Nordisk AS Earnings
Novo Nordisk AS Earnings Report: Per Share Novo Nordisk AS Earnings Q1 Q2 Q3 and Q4 last year and next year.
Novo Nordisk AS Forecast Revenue Growth
Novo Nordisk AS Stock Analysis: Historical quarterly revenues per share for Novo Nordisk AS and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.72 per share.
* Novo Nordisk AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.